91 related articles for article (PubMed ID: 16223530)
1. Alterations in cell-mediated immune response in subacute sclerosing panencephalitis.
Yentür SP; Gürses C; Demirbilek V; Yilmaz G; Onal AE; Yapici Z; Yalçinkaya C; Cokar O; Gökyiğit A; Saruhan-Direskeneli G
J Neuroimmunol; 2005 Dec; 170(1-2):179-85. PubMed ID: 16223530
[TBL] [Abstract][Full Text] [Related]
2. Subacute sclerosing panencephalitis and multiple sclerosis: in vitro measles immunity and sensitization to myelin basic protein.
Sheremata W; Sazant A; Watters G
Can Med Assoc J; 1978 Mar; 118(5):509-13. PubMed ID: 343902
[TBL] [Abstract][Full Text] [Related]
3. Analysis of serum and cerebrospinal fluid cytokine levels in subacute sclerosing panencephalitis in Papua New Guinea.
Ichiyama T; Siba P; Suarkia D; Reeder J; Takasu T; Miki K; Maeba S; Furukawa S
Cytokine; 2006 Jan; 33(1):17-20. PubMed ID: 16413199
[TBL] [Abstract][Full Text] [Related]
4. Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis.
Aydin OF; Ichiyama T; Anlar B
Brain Dev; 2010 Jun; 32(6):463-6. PubMed ID: 19481385
[TBL] [Abstract][Full Text] [Related]
5. Immune alterations in subacute sclerosing panencephalitis reflect an incompetent response to eliminate the measles virus.
Yentür SP; Demirbilek V; Gurses C; Baris S; Kuru U; Ayta S; Yapici Z; Adin-Cinar S; Uysal S; Celik Yilmaz G; Onal E; Cokar O; Saruhan-Direskeneli G
PLoS One; 2021; 16(1):e0245077. PubMed ID: 33411786
[TBL] [Abstract][Full Text] [Related]
6. Elevated interleukin-12 and CXCL10 in subacute sclerosing panencephalitis.
Saruhan-Direskeneli G; Gürses C; Demirbilek V; Yentür SP; Yilmaz G; Onal E; Yapici Z; Yalçinkaya C; Cokar O; Akman-Demir G; Gökyiğit A
Cytokine; 2005 Oct; 32(2):104-10. PubMed ID: 16226466
[TBL] [Abstract][Full Text] [Related]
7. Subacute sclerosing panencephalitis (SSPE).
Lapointe N; Geoffroy G; McLaughlin B; Mongeau JG
Birth Defects Orig Artic Ser; 1975; 11(1):239-43. PubMed ID: 1096980
[TBL] [Abstract][Full Text] [Related]
8. Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus.
Wechsler SL; Weiner HL; Fields BN
J Immunol; 1979 Aug; 123(2):884-9. PubMed ID: 458157
[TBL] [Abstract][Full Text] [Related]
9. Analysis of MxA, IL-4, and IRF-1 genes in Filipino patients with subacute sclerosing panencephalitis.
Pipo-Deveza JR; Kusuhara K; Silao CL; Lukban MB; Salonga AM; Sanchez BC; Kira R; Takemoto M; Torisu H; Hara T
Neuropediatrics; 2006 Aug; 37(4):222-8. PubMed ID: 17177148
[TBL] [Abstract][Full Text] [Related]
10. Impaired human leukocyte antigen-restricted measles virus-specific cytotoxic T-cell response in subacute sclerosing panencephalitis.
Dhib-Jalbut S; Jacobson S; McFarlin DE; McFarland HF
Ann Neurol; 1989 Mar; 25(3):272-80. PubMed ID: 2786368
[TBL] [Abstract][Full Text] [Related]
11. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
[TBL] [Abstract][Full Text] [Related]
12. Virological and immunological studies in experimental SSPE.
Johnson KP; Byington DP; Gaddis L
Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):495-507. PubMed ID: 616550
[TBL] [Abstract][Full Text] [Related]
13. Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens.
Venken K; Hellings N; Hensen K; Rummens JL; Stinissen P
J Neuroimmunol; 2010 Sep; 226(1-2):185-91. PubMed ID: 20554330
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of in vitro lymphocyte-mediated cytotoxicity against measles virus in SSPE.
Kreth WH; Käckell MY; ter Meulen V
J Immunol; 1975 Mar; 114(3):1042-6. PubMed ID: 1089723
[TBL] [Abstract][Full Text] [Related]
15. Do antibodies to myelin basic protein isolated from multiple sclerosis cross-react with measles and other common virus antigens?
Bernard CC; Townsend E; Randell VB; Williamson HG
Clin Exp Immunol; 1983 Apr; 52(1):98-106. PubMed ID: 6190599
[TBL] [Abstract][Full Text] [Related]
16. [Influence of patient age and year of developing the disease on immunologic response to measles virus in subacute sclerosing panencephalitis (SSPE)].
Gut W; Kowalewska A
Med Dosw Mikrobiol; 1993; 45(4):503-10. PubMed ID: 8189831
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of anti-CD9 antibodies in the cerebrospinal fluid of patients with subacute sclerosing panencephalitis.
Shimizu T; Matsuishi T; Iwamoto R; Handa K; Yoshioka H; Kato H; Ueda S; Hara H; Tabira T; Mekada E
J Infect Dis; 2002 May; 185(9):1346-50. PubMed ID: 12001055
[TBL] [Abstract][Full Text] [Related]
18. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
Zilber N; Rannon L; Alter M; Kahana E
Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
[TBL] [Abstract][Full Text] [Related]
19. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.
Linington C; Berger T; Perry L; Weerth S; Hinze-Selch D; Zhang Y; Lu HC; Lassmann H; Wekerle H
Eur J Immunol; 1993 Jun; 23(6):1364-72. PubMed ID: 7684687
[TBL] [Abstract][Full Text] [Related]
20. Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.
Bellini WJ; Rota JS; Lowe LE; Katz RS; Dyken PR; Zaki SR; Shieh WJ; Rota PA
J Infect Dis; 2005 Nov; 192(10):1686-93. PubMed ID: 16235165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
